Historical record - last NADAC effective date: 2/17/2021

Product Information

LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Lifestar Pharma LLC, priced at $0.1691 per EA under NDC 70756080730. Its NADAC has been published 146 times since May 16, 2018.

FDA first approved this application on Aug 30, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LANSOPRAZOLE DR 30 MG CAPSULE

Lansoprazole
$0.1691per EA

Strength

30 mg/1

NDC

70756080730

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Effective Date

2/17/2021

Active Ingredients

LANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA205868

FDA Approved

8/30/2017

TE Code

AB

On Market Since

6/4/2018

Pharmacological Classes

Inhibition Gastric Acid Secretion
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 146 times since May 16, 2018, and over the history we have for it it has declined 18.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1691 per EA
All-time high$0.2139 (Aug 15, 2018)
All-time low$0.1519 (Sep 23, 2020)
Median price$0.1739
Average price$0.1759
Largest weekly change-14.2% (Nov 21, 2018)
Weeks tracked146
Tracking sinceMay 16, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-18.2%

Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Lifestar Pharma LLC, is $0.1691 per EA (NDC 70756080730), effective Feb 24, 2021.

How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 18.2%. It has been tracked across 146 weekly CMS publications since May 16, 2018.

What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?

Since May 16, 2018, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.1519 (Sep 23, 2020) to a high of $0.2139 (Aug 15, 2018), with a median of $0.1739 per EA.

Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 30 MG CAPSULE, is $0.1071 per EA — about 37% below LANSOPRAZOLE DR 30 MG CAPSULE.

Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?

LANSOPRAZOLE DR 30 MG CAPSULE (NDC 70756080730) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.